Latest "Mitchell International, Inc." News Stories - Page: 20

02:50 EDT 22nd March 2019 | BioPortfolio

Here are the most relevant search results for "Mitchell International, Inc." found in our extensive news archives from over 250 global news sources.

More Information about Mitchell International, Inc. on BioPortfolio

In addition to our news stories we have dozens of PubMed Articles about Mitchell International, Inc. for you to read. Along with our medical data and news we also list Mitchell International, Inc. Clinical Trials, which are updated daily. BioPortfolio also has a large database of Mitchell International, Inc. Companies for you to search.

Showing "Mitchell International" News Articles 476–500 of 5,200+

Saturday 2nd March 2019

TATOUAGES : Sont-ils un marqueur de mode de vie et de santé ?

Les tatouages ​​sont-ils liés à la santé des personnes, sont-ils un marqueur de comportements à risque, se sont interrogés ces chercheurs de de l'Université de Miami. Eh bien, pas vraiment ou pas tout à fait, conclut cette enquête à paraître dans l’International Journal of Dermatology et dont nous livrons ici les résultats préliminaires. De précédentes […]

ANLEIHEN-Woche KW9 - 2019: R-LOGITECH, Katjes International, PNE, Dt. Mittelstandsanleihen FONDS, PCC, gamigo, Mologen, Exporo,…

Die Woche vom 25.02. bis 01.03.2019 (KW9) steht am KMU-Anleihen-Markt im Zeichen der angekündigten 100 Mio. Euro-Aufstockung der 8,50%-R-LOGITECH-Anleihe. Die Unternehmensanleihe 2018/23 (ISIN: DE...

Friday 1st March 2019

PanTheryx Presents Positive Results from Two New DiaResQ Studies at its 2019 International Scientific Symposium

New clinical data and case studies highlight the use of DiaResQ in a range of real world settings, from hospitals to disaster relief, in its first annual scientific meeting PanTheryx, a biotechnology company committed to realizing the potential of novel interventions to address a wide range of serious GI microbiome related health conditions, announced ...

[Comment] Will dual Japanese encephalitis and measles-rubella vaccination hinder measles and rubella eradication?

In The Lancet Infectious Diseases, Yan Li and colleagues1 present a multicentre randomised controlled trial to assess whether live-attenuated Japanese encephalitis vaccine (LJEV) impairs measles and rubella antibody responses to coadministered measles-rubella vaccine. China's National Immunisation Programme has recommended dual LJEV and measles-rubella vaccination at 8 months of age since 2008 but...

Endo gains on favorable FDA drug compounding decision

Endo International Plc said on Friday the U.S. health regulator has decided not to include blood pressure treatment vasopressin in its list of drugs that can be used in compounding, in a boost to the drugmaker that makes the on...

Endo Announces FDA Decision Not to Include Vasopressin on 503B Bulks List

DUBLIN, March 1, 2019 /PRNewswire/ -- Endo International plc ("Endo") (NASDAQ: ENDP) today announced that the U.S. Food and Drug Administration (FDA) has determined that there is no clinical need ...

DGAP-News: Chemesis International Inc.: Chemesis International Inc. meldet Abschluss einer Privatplatzierung in Höhe von 2.760.000 Dollar und Abkommen für eine Aktienzeichnungsfazilität in Höhe von 10.000.000 Dollar (deutsch)

Chemesis International Inc.: Chemesis International Inc. meldet Abschluss einer Privatplatzierung in Höhe von 2.760.000 Dollar und Abkommen für eine Aktienzeichnungsfazilität in Höhe von 10.000.000...

EMA Panel Backs Zanamivir IV for Complicated, Severe Influenza

The EMA's Committee for Medicinal Products for Human Use recommended marketing authorization under exceptional circumstances for zanamivir for complicated and potentially life-threatening influenza. International Approvals

EU Panel OKs Sotagliflozin for Some With Type 1 Diabetes

The decision includes a list of requirements for use of the SGLT1/ SGLT2 inhibitor in select patients to minimize DKA risk. The EU approval will be the first worldwide for sotagliflozin. International Approvals

Global Perspective Newsletter for February 2019

The February 2019 edition of our Global Perspective Newsletter is now available. Read the latest news from ADI, our partners and member associations, including updates from the WHO Executive Board; the Korean National Institute (KNID)'s symposium; Dementia Alliance International, and much more. [read it now]

EU Panel Backs Risankizumab (Skyrizi) for Plaque Psoriasis

The interleukin-23 inhibitor is for treatment of moderate to severe plaque psoriasis in adults who are candidates for systemic therapy. International Approvals

Morgan Stanley Executive Director Joins Vinzan International

Today, Vinzan International Inc., a Toronto-based cannabis trading company, is pleased to announce the appointment of Donald Stewart as Chief Financial Officer. Donald brings 20 years of leadership experience in capital markets to Vinzan International as they prepare for their 2019 initial public offering. Donald comes to Vinzan International after nearly ...

Ocular Therapeutix™ To Report Fourth Quarter and Year End 2018 Financial Results

Ocular Therapeutix™, Inc. (NASDAQ: OCUL), a biopharmaceutical company focused on the formulation, development, and commercialization of innovative therapies for diseases and conditions of the eye, today announced that it will report fourth quarter and year ended December 31, 2018 financial results on Thursday, March 7, 2019. Following distribution o...

Gummy Smiles in Longview, TX, Transformed by Dr. Alejandro Kovacs, Dual Board-Certified Periodontist and Prosthodontist

Dr. Alejandro Kovacs, dual board-certified periodontist and prosthodontist, welcomes patients in need of a “gum lift” for aesthetic or functional crown lengthening in Longview, TX. Correcting a gummy smile improves smile aesthetics and creates room for the restoration of damaged or decayed teeth. LONGVIEW, Texas (PRWEB) March 01, 2019 Dual board-certified periodontist and prosthodontist, Dr. ...

European Panel Endorses Lorlatinib for Lung Cancer

The Committee for Medicinal Products for Human Use has recommended marketing authorization for the drug for ALK-positive advanced non-small cell lung cancer. International Approvals

CHMP Backs Factor Xa Reversal Agent Andexanet (Ondexxya)

Andexanet alfa, approved in the United States in 2018, would be the first drug approved for reversing major bleeds with the factor Xa inhibitors apixaban and rivaroxaban in Europe. International Approvals

Scientists Find 5 New Genes That Sway Alzheimer's Risk

FRIDAY, March 1, 2019 -- The largest study to date of the genetic underpinnings of Alzheimer's has uncovered five new gene mutations that make people more vulnerable to the memory-robbing disease. The international team of scientists analyzed the...

Neil Riordan, PA, PhD Presents at the 5th Annual Perinatal Stem Cell Society Congress in Salt Lake City, UT on Thursday, February 28th

Neil Riordan, PA, PhD presented “Results From Panama Clinical Trials Using Human Umbilical Cord Tissue-Derived Mesenchymal Stem Cells (HUCT-MSCs) for Multiple Sclerosis and Autism” at the 5th Annual Perinatal Stem Cell Society Congress in Salt Lake City, UT on Thursday, February 28th. SALT LAKE CITY (PRWEB) March 01, 2019 Neil Riordan, PA, PhD presented “Results From Panama Clinical Trials ...

SmallCap-Investor Interview mit Lucas Birdsall von ICC International Cannabis Corp. (WKN A2N6DJ)

Deutsches Intro und Outro - Interview in Englisch!- Lucas, ihr seid extrem aktiv und vor allem in Europa. Erkläre uns bitte kurz eure Strategie?- Wo seht ihr in eurer Strategie noch den größten .. ...

Neurimmune Appoints John Dellapa as General Counsel

SCHLIEREN / ZURICH, Switzerland, March 01, 2019 / B3C newswire / -- Neurimmune today announced the appointment of John Dellapa as General Counsel. John joins Neurimmune from the Boston office of Mintz, Levin, Cohn, Ferris, Glovsky and Popeo, an AmLaw 100 law firm widely recognized for its outstanding life sciences practice. As a corporate transactional lawyer with more than 30 years of experience...

On International Women's Day, Nonprofit CEO Reminds That Gender Equality Begins By Fighting World Poverty

KANSAS CITY, Mo. (PRWEB) March 01, 2019 Next Friday, as attention turns toward building a more gender-balanced world in recognition of International Women’s Day, one organization -- Children International – is squarely focused on batting the number one problem that upsets that balance. Pover...

Investor Ideas Potcasts Cannabis News and Stocks on the Move: The Flowr Corporation (TSXV: FLWR) (OTC: FLWPF), Village Farms International, Inc. (TSX:VFF) (OTC: VFFIF) and Canopy Growth (TSX: WEED) (NYSE: CGC)

Delta, Kelowna, BC - March 1, 2019 ( Newswire), a global news source covering leading sectors including marijuana and hemp stocks and its potcast site, release today's edition of potcastsCM - cannabis news and stocks to watch plus insight from thought leaders and experts.

Thursday 28th February 2019

[Articles] Association between interpregnancy interval and adverse birth outcomes in women with a previous stillbirth: an international cohort study

Conception within 12 months of a stillbirth was common and was not associated with increased risk of adverse outcomes in the subsequent pregnancy. These findings could be used when counselling women who are planning future pregnancies after a stillbirth and for informing future recommendations for pregnancy spacing in a high-income setting.

Two genes explain variation in color and behavior in the wall lizard

(Uppsala University) How are reptiles capable of generating such a diversity of bright colors? And how is it possible that within a single population of the same species, different individuals exhibit strikingly different coloration patterns? In a new paper published in the journal PNAS an international team of scientists, led by researchers from CIBIO/InBIO (University of Porto) and Uppsala Unive...

Invacare Corporation to Participate in the Morgan Stanley Healthcare Corporate Access Day and International Seating Symposium

Matthew E. Monaghan, chairman, president and chief executive officer and Kathleen P. Leneghan, senior vice president and chief financial officer of Invacare Corporation (NYSE:IVC) (“Invacare” or the “company”), will participate in the 2019 Morgan Stanley Healthcare Corporate Access Day at the Boston Harbor Hotel in Boston, MA on Tuesday, March 1...

Quick Search


News Quicklinks